Veterinary Medicines

MARFLOQUIN 20 MG/ML SOLUTION FOR INJECTION FOR CATTLE (CALVES) AND PIGS

Not authorised
  • Marbofloxacin
Download as PDF

Product identification

Medicine name:
MARFLOQUIN 20 MG/ML SOLUTION FOR INJECTION FOR CATTLE (CALVES) AND PIGS
MARFLOQUIN 20 mg/ml soluzione iniettabile
Active substance:
  • Marbofloxacin
Target species:
  • Cattle (calf)
  • Pig
Route of administration:
  • Intramuscular use
  • Subcutaneous use

Product details

Active substance and strength:
  • Marbofloxacin
    20.00
    milligram(s)
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Solution for injection
Withdrawal period by route of administration:
  • Intramuscular use
    • Cattle (calf)
      • Meat and offal
        6
        day
    • Pig
      • Meat and offal
        4
        day
  • Subcutaneous use
    • Cattle (calf)
      • Meat and offal
        6
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QJ01MA93
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Surrendered
Authorised in:
  • Italy
Package description:
  • Bottle 100 ml solution for injection, in a box
  • Bottle of 50 ml solution for injection, in a box

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Generic application (Article 13(1) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • KRKA tovarna zdravil d.d. Novo mesto
Marketing authorisation date:
Manufacturing sites for batch release:
  • KRKA tovarna zdravil d.d. Novo mesto
Responsible authority:
  • Ministry Of Health
Authorisation number:
  • 104312
Date of authorisation status change:
Reference member state:
  • France
Procedure number:
  • FR/V/0223/001
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."